anmelden
OMX Nordic 40
2.636,21
PKT
-39,11
PKT
-1,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.07.24 | Nokia Neutral | UBS AG | |
| 04.07.24 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 04.07.24 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | Nokia Hold | Jefferies & Company Inc. | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.07.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 02.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.07.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 01.07.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 01.07.24 | Nokia Neutral | UBS AG | |
| 01.07.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 28.06.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 28.06.24 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 28.06.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 28.06.24 | Novo Nordisk Neutral | UBS AG | |
| 28.06.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 27.06.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.06.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.06.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 27.06.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.06.24 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 26.06.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.06.24 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 26.06.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 25.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 25.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.06.24 | Nokia Underweight | Barclays Capital | |
| 24.06.24 | AstraZeneca Overweight | Barclays Capital | |
| 24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.06.24 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 18.06.24 | Volvo (B) Buy | Deutsche Bank AG | |
| 18.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. |